Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. For this reason, the compound was abandoned by its developer and never marketed.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

AUGUST 10, 2021

The UK is a significant country for us for many reasons, and we are proud to be able to offer a medicine, that has been developed and is manufactured here, to even more patients across the UK. GW’s development programme represents the only well-controlled clinical evaluation of a cannabinoid medication for patients with refractory epilepsy.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Approved Cannabinoid-Based Medications.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94

Strains Cannabinoids Research and Development Indica 94

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. The two cannabinoids can also cause very different effects in other ways.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Approved Cannabinoid-Based Medications.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

The Cannigma

JUNE 29, 2021

Though the distinction between these terms may seem trivial at first glance, it is in fact crucial for cannabis research, and therefore also for consumers and regulators as well. Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Cannabis Law Report

JANUARY 16, 2022

Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland. Some conditions for which cannabis-based treatment has been advocated include epilepsy, neuropathic pain and chronic widespread pain as well as appetite problems, nausea and vomiting and pain in cancer patients.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

CannaMD

AUGUST 19, 2020

Researchers with Microbiology and Molecular Biology Reviews elaborate: The term “cytokine storm” calls up vivid images of an immune system gone awry and an inflammatory response flaring out of control. Marijuana cannabinoid, CBD. ” And their alternative strategy of choice? CBD: Cytokine Storm Fighter.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Cannabis Law Report

APRIL 4, 2019

House of Hemp hope to build on existing medical research and further explore the potential of cannabis as a healing plant. A big part of the licensing process will be that it will enable cannabis researchers to take their work further and conclusively prove what medical benefits, if any, the plant yields.

Cultivation 40

Cultivation Research and Development Chronic Pain Data 40

Cannabis Law Report

JULY 12, 2019

By: James Holley, Molecular Biologist, Scientific Officer, Mike Robinson, Co-founder, Research Institute, and Dr. David Ostrow, M.D., Research Director. International Cannabinoid Cancer Research Institute (Draft 5). Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Healer

JUNE 28, 2019

Cannabinoids have been shown to reduce the intensity of pain, including inflammatory pain, neuropathic pain, and cancer pain. Cannabinoids reduce spasticity and the pain associated with muscle spasm. In certain situations, cannabinoids can increase the intensity of acute pain. Nabiximols (Nabiximols is the U.S.

Cannabinoids 52

Cannabinoids THC Therapy Patients 52

Healer

JANUARY 17, 2022

Cannabigerol (CBG) is one of the 100+ cannabinoids found in cannabis and hemp plants. The most well-known cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD), but there’s growing interest in the potential benefits of CBG, which has only recently become available in significant potencies.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Healer

JANUARY 17, 2022

Cannabigerol (CBG) is one of the 100+ cannabinoids found in cannabis and hemp plants. The most well-known cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD), but there’s growing interest in the potential benefits of CBG, which has only recently become available in significant potencies.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

WeedAdvisor

APRIL 1, 2019

CBD Oil for dogs, cats and other pets is a natural development of the cannabidiol (CBD) craze. As anecdotal evidence began piling up, some companies decided that CBD’s reported effects on epilepsy (which has been heavily proven), anxiety, insomnia, pain and inflammation – among others – could work on dogs, cats and other pets.

Pets 49

Pets Oil CBD Research and Development 49

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. At the same time, the outlook on cannabis research data is largely positive. Primary sources most frequently used in these reports are peer-reviewed journals or government reports, voices from medical associations or foundations, as well as government and university researchers.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

DECEMBER 9, 2019

After all, CBD is only one of the hundreds of documented cannabinoids found in cannabis and hemp. Although research on CBD is still in its infancy, to date there have been dozens of studies with more on the horizon. Although research on CBD is still in its infancy, to date there have been dozens of studies with more on the horizon.

Pets 59

Pets CBD Research and Development Epilepsy 59

Cannabis Info

MARCH 12, 2019

There is no data recorded on any federal database anywhere. In every systemized study of cannabinoids as medication, one thing is clear. Even when cannabinoids stop seizures, they are working to moderate systematic functioning. The first tender bid for growers noted that delivered cannabis could be 100% pure cannabinoid.

Research and Development 45

Research and Development Concentrates Cannabinoids Cannabis 45

Green Relief

MAY 13, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. It is the most commonly identified cause of epilepsy among adults. government-held patent on “Cannabinoids as antioxidants and neuroprotectants.”.

THC 64

THC CBD Cannabinoids Research and Development 64

StrainConnect

FEBRUARY 8, 2019

If you’re here, it means you may be interested in CBD for yourself, a friend or a loved one, or perhaps you’re an industry professional conducting research. Consider us your home for CBD, hemp and cannabis research, education, and personalized product recommendations. The difference between the cannabinoids CBD and THC.

Hemp 57

Hemp CBD Cannabinoids Sativa 57

Green Relief

MAY 12, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. It is the most commonly identified cause of epilepsy among adults. government-held patent on “Cannabinoids as antioxidants and neuroprotectants.”.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. The Center for Medical Cannabis Research at the UC San Diego School of Medicine received a donation of $4.7

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

JANUARY 27, 2020

The US Food and Drug Administration (FDA) asserts its case clearly on its website, emphasising that it has approved only one product, and that’s a prescription drug to treat two rare forms of epilepsy. But what if a view develops suggesting that all this CBD could be causing health problems, not just resolving them?

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

NOVEMBER 22, 2019

Malaysia’s health minister approved the cultivation of hemp for research purposes. Member of the European Parliament Miriam Dali urged the European Commission to start seriously investing in research and development in medical cannabis. Eighteen companies have applied to be among the five.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

Cannabis Law Report

MARCH 3, 2020

Million to Fuel Growth in Florida, Arizona and Internationally : “ Alternative Medical Enterprises, LLC (“AltMed”), a fully integrated company that brings pharmaceutical industry precision to the development, production and dispensing of medical cannabis, today announced it has closed a private placement financing of $35.4

Dispensary 64

Dispensary Patients Cannabis Wellness and Beauty 64

Cannabis Law Report

OCTOBER 17, 2019

Food and beverage makers are gearing up to sell CBD-containing products, when allowed by regulators, including Lagunitas Brewing, which has developed a cannabis-infused IPA and a THC-based sparkling water, and Ben & Jerry’s, which plans to offer a CBD-infused ice cream. THC is just one of the cannabinoids in the Cannabis sativa L.

Law 40

Law Seed-To-Sale Hemp Recreational 40